Cargando…

Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates

Infection with high-risk (hr) human papillomavirus (HPV) is considered the necessary cause of cervical cancer. Vaccination against HPV16 and 18 types, which are responsible of about 75% of cervical cancer worldwide, is expected to have a major global impact on cervical cancer occurrence. Valid estim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baussano, Iacopo, Elfström, K. Miriam, Lazzarato, Fulvio, Gillio-Tos, Anna, De Marco, Laura, Carozzi, Francesca, Del Mistro, Annarosa, Dillner, Joakim, Franceschi, Silvia, Ronco, Guglielmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882251/ https://www.ncbi.nlm.nih.gov/pubmed/24400036 http://dx.doi.org/10.1371/journal.pone.0081171

Ejemplares similares

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Impacts of human papillomavirus vaccination for different populations: A modeling study
por: Baussano, Iacopo, et al.
Publicado: (2018)

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
por: Baussano, Iacopo, et al.
Publicado: (2017)

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
por: Baussano, Iacopo, et al.
Publicado: (2013)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
por: Baussano, Iacopo, et al.
Publicado: (2016)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
por: Del Mistro, Annarosa, et al.
Publicado: (2018)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
por: Ngabo, Fidele, et al.
Publicado: (2016)

Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
por: Martello, Gessica, et al.
Publicado: (2023)

Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study
por: Clifford, Gary M., et al.
Publicado: (2023)

A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18–26 years
por: Giambi, Cristina, et al.
Publicado: (2013)

Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan)
por: Baussano, Iacopo, et al.
Publicado: (2017)

Patterns of Human Papillomavirus Types in Multiple Infections: An Analysis in Women and Men of the High Throughput Human Papillomavirus Monitoring Study
por: Vaccarella, Salvatore, et al.
Publicado: (2013)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection
por: Baussano, Iacopo, et al.
Publicado: (2017)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18
por: Zorzato, Pierpaolo, et al.
Publicado: (2021)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing
por: Gillio-Tos, Anna, et al.
Publicado: (2018)

Human papillomavirus typing of invasive cervical cancers in Italy
por: Del Mistro, Annarosa, et al.
Publicado: (2006)

Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys
por: Sayinzoga, Felix, et al.
Publicado: (2023)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
por: Baussano, Iacopo, et al.
Publicado: (2021)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Options for design of real-world impact studies of single-dose vaccine schedules
por: Franceschi, Silvia, et al.
Publicado: (2018)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

The Launch of an International Animal Papillomavirus Reference Center
por: Van Doorslaer, Koenraad, et al.
Publicado: (2019)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan
por: Tshomo, Ugyen, et al.
Publicado: (2017)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
por: Turner, Hugo C., et al.
Publicado: (2013)

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
por: Tshomo, Ugyen, et al.
Publicado: (2014)

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy
por: Lupato, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6j3ocki05i08032pussis7h087